The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP FIGI (to the nearest dollar) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ALPHABET INC CAP STK CL C 02079K107   18,488,679 15,900 SH   SOLE   15,900 0 0
DECIPHERA PHARMACEUTICALS IN COM 24344T101   13,945,020 338,718 SH   SOLE   338,718 0 0
FREEPORT-MCMORAN INC CL B 35671D857   8,437,500 1,250,000 SH   SOLE   1,250,000 0 0
LIVEPERSON INC COM 538146101   6,949,397 305,468 SH   SOLE   305,468 0 0
PAYPAL HLDGS INC COM 70450Y103   10,722,880 112,000 SH   SOLE   112,000 0 0
SAGE THERAPEUTICS INC COM 78667J108   8,865,606 308,691 SH   SOLE   308,691 0 0
SYNNEX CORP COM 87162W100   8,916,299 121,974 SH   SOLE   121,974 0 0
VERTEX PHARMACEUTICALS INC COM 92532F100   14,633,925 61,500 SH   SOLE   61,500 0 0